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Abstract
Background: To date, several studies concerning the effects of induced abortion (IA) on women’s later psychosocial
well-being and future delivery complications have been published. However, the lack of reports on woman’s physical
well-being during their first full-term pregnancy occurring after IA is what inspired the current study. Here, we evaluate
the physical well-being and use of maternity services of first-time mothers with a history of IA.
Methods: Finnish National Birth Registry data from 2008 to 2010 were linked with the Induced Abortion Registry data
from 1983 to 2007. After excluding first-time mothers with a history of miscarriage, ectopic pregnancy or delivery,
57,406 mothers were eligible for the study, with 5,167 (9.0 %) having experienced prior IA. Data from the pregnancy
follow-up visits were evaluated and compared between IA mothers and primiparous mothers.
Results: Women with IA had higher rates of smoking after the first trimester and were more likely to be overweight
(body mass index >25 kg/m2) than the control group mothers. A higher use of maternity health clinic (MHC) services,
thrombosis prophylaxis and participation in a second trimester ultrasound and amniotic fluid sample testing were
evident in IA mothers, whereas the likelihood of assisted fertilisation procedure(s) was elevated in the control group.
A shorter interpregnancy interval (IPI) seemed to contribute to a late first MHC visit and first trimester serum screening
test participation, a higher incidence of placenta samples and an increased presence of preeclampsia and maternal
care for poor foetal growth.
Conclusions: IA is associated with being overweight before the subsequent pregnancy and with smoking after the
first trimester. More frequent pregnancy follow-up visits in the IA group may be due to greater participation in
the placenta sample testing and use of thrombosis prophylaxis. No association between IA and preeclampsia,
hypertension, gestational diabetes or preterm premature rupture of membranes was evident in the pregnancy
parameters. According to our findings, experiencing IA decreased the need for fertilisation procedures before
the next pregnancy when compared to primiparous mothers. Among the IA mothers, the short IPI seemed to
contribute to the higher risk for preeclampsia and maternal care for poor foetal growth. However, more research
is needed around the IPI before establishing its effect on later pregnancy.
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Background
Induced abortion (IA) is something many women
undergo at some point in their lives. According to
World Health Organization’s (WHO) statistics, 30 % of
all pregnancies in Europe end in termination, with the
highest and lowest sub-regional termination rates world-
wide being in Eastern and Western Europe at 43 % and
12 %, respectively, per 1,000 fertile women [1]. In
Finland, IA during the first trimester is considered to be
a common procedure in the public health care system,
with the decision to seek termination being made by the
pregnant woman (and her partner). According to the
National Institute for Health and Welfare [2], in 2013,
there were 10,120 IAs (8.7/1,000 fertile women) per-
formed in Finland, with the age group of 20–24 having
the highest number of IAs. Socioeconomic background
was the most common indication in 91.8 % of IAs per-
formed. Medical procedures for IA were introduced in
Finland in 2000; today, they account for approximately
95 % of all terminations performed (with a combination
of antiprogestin mifepristone and prostaglandin miso-
prostol used as termination drugs). Over 92 % of all IAs
are performed in the first trimester.
Various studies of the effects of IA on woman’s well-
being and later deliveries have been published. In Nordic
countries with permissive legislation, society has a neutral
attitude toward IA procedures and an effective maternity
health care system – the psychosocial consequences of IA
seem to be minimal [3–7]. Maternity health clinic (MHC)
services [8], aiming to monitor and screen the health and
well-being of the mother and the unborn baby, and the
data from the follow-up visits, are less studied in regard to
the effect of terminating a pregnancy. A lack of consistent
results regarding pregnancy parameters documented in
MHCs (when preventive methods aiding the future deliv-
ery could be systematically applied) and the delivery out-
comes in pregnancy after IA (e.g. preterm birth [9–16],
low birth weight [10, 11], preterm premature rupture of
membranes [16, 17] and preeclampsia [18, 19]) inspired
this registry-based study. It analyses a large cohort group
of mothers to evaluate the effect of IA and its possible
complications first in pregnancy and later in delivery
parameters. A pregnancy, whether ending in termination
or full-term delivery, is always a physiologically deviant
situation for the body. Women with a history of IA have
already experienced changes in their pregnancy hormone
levels as well as in the functioning of the uterus due to
being pregnant before and having experienced either a
medically or surgically induced abortion in comparison
with primiparous women. However, the physical experi-
ence cannot be directly compared with a full-term
pregnancy because of the short time period; therefore,
only short-term changes are evident in the uterus and
hormones compared with a full-term pregnancy. By
examining the pregnancy variables between women with a
history of IA and primiparous women, we hope to add
knowledge about IAs’ effects on pregnancy follow-up pa-
rameters and how to better predict the possible deviant
situations presenting in perinatal time related to the prior
IA. We organised the cases into three groups according to
the interpregnancy interval (IPI) and gained information
on how the pregnancy parameters related to this time
interval. The objective of this study was to evaluate
whether the use of MHC services and the results from
physical examinations differed between first-time mothers
with prior IA and primiparous mothers. Being a rather
common procedure in public health care, the impact of IA
on a following pregnancy should be reported to determine
whether there is a need for extra support for this group of
mothers. Due to this study’s focus on women becoming
mothers for the first time, the possible confounding
factor(s) of physical reactions or changes related to experi-
encing a previous full-term pregnancy were excluded.
Methods
The National Birth Registry records from 2008 to 2010
were used, in addition to the Registry for Induced Abor-
tions from 1983 to 2007, to locate women becoming
mothers for the first time in 2008–2010 to determine the
groups for this study. The termination group (N = 5,167)
consisted of women becoming mothers for the first time
with a history of IA. Women pregnant with their first
child and with no prior pregnancy history were chosen for
the non-termination group (N = 52,239). Women with
prior miscarriage, ectopic pregnancy or deliveries were ex-
cluded from the study. The data from MHC follow-up
visits were attained from the National Birth Registry re-
cords, and all of the available follow-up parameters were
examined between the two groups. For an unknown
reason, the mothers’ occupations were not recorded in the
National Birth Registry records in 95.0 % of the cases of
IA mothers (N = 4,910) and 46.6 % of the cases of non-IA
mothers (N = 24,338). For this reason, we were forced to
exclude occupational status from the background charac-
teristics. Other parameters in the National Birth Registry
data were routinely recorded, with no other high rates of
missing data.
A blood glucose (BG) tolerance test was diagnosed as
pathological if it had one of the following three values: at
0 h, BG ≥5.3 mmol/l; at 1 h, BG ≥10.0 mmol/l; at
2 h, BG ≥8.6 mmol/l. The tolerance test is generally
performed at 24–28 pregnancy weeks, but if the risk for
gestational diabetes mellitus (DM) is thought to be great
(e.g. BMI >35 kg/m2, type 2 DM in near family, oral
corticosteroid treatment), the tolerance test may be
performed during pregnancy weeks 12–16 for the first
time and again during pregnancy weeks 24–28 if needed.
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Statistical analysis
Distributions were evaluated with the Shapiro–Wilk test
of normality. The group differences in categorical back-
ground factors were tested using Pearson’s chi-squared
test and logistic regression with Tukey’s multiple compari-
sons adjustment. The group differences in continuous
background factors were tested using an analysis of vari-
ance (ANOVA) with Tukey’s multiple comparisons adjust-
ment. Additional multivariable model was used to assess
confounding effects with certain background variables. All
analyses were conducted with the SAS System for
Windows version 9.4 (SAS Institute Inc., Cary, NC, USA).
Results
The IA mothers were more often aged between 20 and
24 years or over 35 years (p < 0.0001), more likely to
smoke after the first trimester of the on-going pregnancy
(p < 0.0001) and less likely cohabiting (p < 0.0001) than the
non-IA mothers (Table 1). Furthermore, IA mothers were
more often overweight than non-IA mothers (p < 0.0001).
Other than this, there were no significant differences in
the background characteristics of the groups.
The IA mothers had more follow-up visits at MHCs (13.4
vs 13.3, p = 0.0443) and hospitals (3.2 vs 2.9, p < 0.0001)
than non-IA mothers, with the overall pregnancy follow-up
visits totalling up to 16.6 vs 16.2 visits (p < 0.0001), respect-
ively. The IA mothers participated more often in the second
trimester ultrasound screening (83.84 % vs 82.44 %,
p < 0.0112) and the amniotic fluid sample testing (2.44 % vs
1.73 %, p < 0.0004), and they used thrombosis prophylaxis
(1.24 % vs 0.87 %, p < 0.0107) more often during their preg-
nancy than did the non-IA mothers. Experiencing IA
seemed to lessen the likelihood for assisted fertilisation pro-
cedure(s) (1.95 % vs 5.14 %, p < 0.0001) as well as participa-
tion in the first trimester serum screening test (33.44 % vs
34.86 %, p < 0.0432) when compared to the non-IA
mothers. Pathological BG tests were more common in the
IA group, but after adjusting for confounding factors, this
difference disappeared. No statistical differences were evi-
dent between the groups in terms of hospital care during
pregnancy, underuse of MHCs, chorionic villus sample
procedures, bleeding, high blood pressure, prematurity,
anaemia or antenatal corticosteroid use. After adjusting
the analyses for age, cohabiting, smoking and weight, par-
ticipation in the first trimester serum screening test was
no longer significant. Interestingly, underutilisation of
MHCs and participating in the BG tolerance test became
statistically significant only after adjusting for confounding
factors, suggesting that these two factors are more frequent
among non-IA mothers than among IA mothers (Table 2).
When comparing the most common diagnosis between
the groups, a significant difference was observed in gesta-
tional DM, at 5.5 % vs 4.6 % (p = 0.0034) in IA and non-IA
mothers, respectively (Table 3). After adjusting for con-
founding demographic factors, the observed difference
was no longer evident.
Interpregnancy interval (IPI) categorisation revealed
that among women younger than 25, the IPI was often
Table 1 Background demographics of the first-time mothers in the IA and non-IA groups at the beginning of the on-going pregnancy
Variable IA group Non-IA group
n % n % p
Age <20 y 466 9.02 4,578 8.76 <0.0001
20–24 y 1,555 30.09 12,416 23.77
25–29 y 1,683 32.57 19,477 37.28
30–34 y 1,008 19.51 11,850 22.68
35–39 y 375 7.26 3,368 6.45
≥40 y 80 1.55 550 1.05
Living area Urban 3,910 77.47 39,376 77.01 0.2188
Rural 484 9.59 5,292 10.35
Densely populated community 653 12.94 6,461 12.64
Cohabiting Yes 4,039 78.40 45,312 86.89 <0.0001
No 661 12.83 3,588 6.88
Smoking Non-smoking 3,168 62.33 42,794 83.56 <0.0001
Stopped in first trim 652 12.83 3,562 6.96
Smokes after first trim 1,263 24.85 4,856 9.48
BMI (kg/m2) Underweight (<20) 293 5.67 3,548 6,79 <0.0001
Normalweight (20–25) 3,233 62.57 33,949 64.99
Overweight (>25) 1,641 31.76 14,742 28.22
Statistically significant differences indicated with bolded p-values
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shorter than in older women (Table 4). Only in the 35–39
age group was the IPI similar in >12 months and
<6 months when compared to a significantly lower IPI of
6–12 months (7.48 % vs 7.62 % vs 2.81 %, respectively,
p < 0.0001). Women with an IPI of 6–12 months were
more often not cohabiting when compared to women with
an IPI <6 months or and IPI >12 months (17.98 % vs
12.50 % vs 12.04 %, respectively, p = 0.0116). Weight was
not statistically significantly different between the IPI
groups, but smoking after the first trimester was clearly
more common in IPI <12 months (IPI >12 months
23.17 % vs IPI 6–12 months 34.27 % vs IPI <6 months
30.48 %, p = 0.0098).
Table 5 demonstrates the statistically significant differ-
ences between the IPI groups. A late first visit to MHC
was more common among women with an IPI <12 months
when compared to women with an IPI >12 months.
Participation in the first trimester serum screening test was
higher in IPI >12 months than it was in the other intervals.
Placenta samples were taken more often in IPI <12 months
when compared with IPI >12 months. Blood glucose toler-
ance test was performed more often among women with
IPI >12 months. Preeclampsia was more frequent in IPI
<12 months. Furthermore, poor foetal growth was more
common in IPI = 6–12 months compared to other
mothers. The number of hospital and pregnancy check-up
visits seemed to be greater when the IPI was shorter.
Discussion
It seems that women with a history of IA have a tendency
for a higher BMI and are therefore more commonly over-
weight before the following pregnancy than primiparous
Table 2 Pregnancy parameters of the first-time mothers in the IA and non-IA groups
Pregnancy parameter IA group Non-IA group Univariate Adjusted
Mean (SD) CI 95 % Mean (SD) CI 95 % p p Difference 95 % CI
First visit to MCH (days pregnant) 64.7 (42.0) 63.5–65.9 64.8 (40.5) 64.4–65.1 0.9169 0.7785 −0.1752 −1.40–1.05
Number of MHC visits 13.4 (3.8) 13.3–13.5 13.3 (3.8) 13.3–13.3 0.0443 0.0179 0.1359 0.02–0.25
Number of check-ups at hospital 3.2 (2.9) 3.1–3.2 2.9 (2.6) 2.9–3.0 <0.0001 0.0374 0.0802 0.00–0.16
Number of all pregnancy follow-up visits 16.6 (4.8) 16.5–16.7 16.2 (4.6) 16.2–16.3 <0.0001 0.0008 0.2282 0.10–0.36
n % n % p p OR 95 % CI
Late first visits to MHC (> h12 + 0) 348 6.74 3,229 6.18 0.1167 0.7491 1.02 0.91–1.15
Under-utilisation of maternity care 0 12 0.24 129 0.25 1.406 0.69–2.88
1–8 97 1.92 1,249 2.46 0.747 0.60–0.92
>8 4,930 97.84 49,400 97.29 0.0601 0.0165 1
Blood glucose tolerance test performed 2,319 44.88 23,880 45.71 0.2535 0.0393 0.93 0.87–1.00
Pathological blood sugar tolerance level 505 9.77 4,459 8.54 0.0025 0.4104 1.04 0.94–1.16
Participation to first trim serum screening 1,728 33.44 18,208 34.86 0.0432 0.0543 0.94 0.88–1.00
Participation to second trim serum screening 148 2.86 1,447 2.77 0.6896 0.7093 1.03 0.87–1.23
Participation to first trim ultrasound screening 3,785 73.25 37,751 72.27 0.1336 0.0593 1.07 1.00–1.14
Participation to second trim ultrasound screening 4,332 83.84 43,065 82.44 0.0112 <0.0001 1.20 1.11–1.31
Placenta sample taken 52 1.01 497 0.95 0.7076 0.9427 0.99 0.74–1.33
Amniotic fluid sample taken 126 2.44 903 1.73 0.0004 0.0065 1.32 1.08–1.61
Hospital care during pregnancy for…
Bleeding 20 0.39 249 0.48 0.4538 0.2433 0.76 0.48–1.21
High blood pressure 144 2.79 1,489 2.85 0.8265 0.7239 0.97 0.81–1.16
Prematurity 63 1.22 650 1.24 0.9475 0.6770 0.95 0.73–1.23
Other reason 312 6.04 2,900 5.55 0.1533 0.4688 1.05 0.93–1.18
Received any hospital treatment (for any
of the reasons mentioned above)
438 8.48 4,243 8.12 0.3792 0.8956 1.01 0.91–1.12
Fertilisation procedure 101 1.95 2,687 5.14 <0.0001 <0.0001 0.42 0.34–0.51
Thrombosis prophylaxis 64 1.24 454 0.87 0.0107 0.0038 1.49 1.14–1.94
Anaemia 155 3.00 1,525 2.92 0.7293 0.8982 1.01 0.85–1.20
Antenatal corticosteroid treatment 131 2.54 1,390 2.66 0.6176 0.4189 0.93 0.77–1.12
Statistically significant differences indicated with bolded p-values
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women are. Participation in the first trimester serum
screening test was initially higher in IA mothers, but this
difference disappeared after adjusting the analyses for
confounding demographic factors. A higher rate of partici-
pation in the second trimester ultrasound screening was
still evident after the adjustment, suggesting that perhaps
the transition to parenthood becomes stronger in the
second trimester of pregnancy. The amniotic fluid sample
was taken more often in the IA group, possibly because
the mothers in this group were more often over 35 years
of age than the mothers in the control group. Thrombosis
prophylaxis was more common in IA mothers than in
non-IA mothers; this difference was evident even after
adjusting the results for demographic factors. No studies
Table 3 The 10 most frequent diagnoses of the first-time mothers during the on-going pregnancy between the IA and non-IA groups
Diagnosis according to ICD-10 IA group Non-IA group P-value P-value
Frequency % Frequency % Chi-square Adjusted model OR 95 % CI
O13 Gestational hypertension without significant proteinuria 213 4.12 1,982 3.79 0.2406 0.3845 1.07 0.92–1.24
O14.0 Mild to moderate preeclampsia 79 1.53 856 1.64 0.5524 0.5554 0.93 0.74–1.18
O14.0/1/9 All types of preeclampsia 135 2.61 1,458 2.79 0.4567 0.5444 0.95 0.79–1.13
O24.4 Gestational diabetes mellitus 285 5.52 2,409 4.61 0.0034 0.1418 1.10 0.97–1.26
O24.9 Unspecified diabetes mellitus in pregnancy, childbirth
and the puerperium
69 1.34 616 1.18 0.3239 0.8954 1.02 0.79–1.31
O30.0 Multiple gestation 66 1.28 683 1.31 0.8556 0.9129 1.02 0.78–1.31
O32.1 Maternal care for breech presentation 146 2.83 1,654 3.17 0.1802 0.3821 0.93 0.78–1.10
O36.5 Maternal care for known or suspected poor fetal growth 78 1.51 791 1.51 0.9793 0.2455 0.87 0.68–1.10
O42.9 Premature rupture of membranes, unspecified as to
length of time between rupture and onset of labour
90 1.74 935 1.79 0.8036 0.5134 1.08 0.86–1.34
O47.0 False labour before 37 completed weeks of gestation 155 3.00 1,427 2.73 0.2614 0.2103 1.12 0.94–1.32
O48 Late pregnancy 72 1.39 694 1.33 0.6979 0.6831 1.05 0.82–1.35
Statistically significant differences indicated with bolded p-values
Table 4 Distributions of the interpregnancy interval by significantly differing maternal characteristics
<20 20−24 25−29 30−34 35−39 >40
Age (years) n % n % N % n % n % n % p
<6 months 26 24.76 33 31.43 27 25.71 10 9.52 8 7.62 1 0.95 <0.0001
6−12 months 49 27.53 65 36.52 40 22.47 19 10.67 5 2.81 0 0
>12 months 322 7.02 1,363 29.71 1,555 33.89 934 20.36 343 7.48 71 1.55
Yes No N/A
Cohabiting n % n % N % p
<6 months 84 80.77 13 12.50 7 6.73 0.0116
6−12 months 141 79.21 32 17.98 5 2.81
>12 months 3,615 78.98 551 12.04 411 8.98
Underweight Normalweight Overweight
Weight n % n % N % p
<6 months 7 6.67 76 72.38 22 20.95 0.0601
6−12 months 13 7.30 114 64.04 51 28.65
>12 months 229 4.99 2,863 62.40 1,496 32.61





Smoking n % n % N % n % p
<6 months 64 60.95 8 7.62 32 30.48 1 0.95 0.0098
6−12 months 99 55.62 16 8.99 61 34.27 2 1.12
>12 months 2,865 62.45 596 12.99 1,063 23.17 64 1.39
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suggesting this same association were found in the
PubMed/MEDLINE search. This finding is challenging to
explain, and the clinical significance of the finding may be
minimal. Higher participation in amniotic fluid sample test-
ing and use of thrombosis prophylaxis may have contrib-
uted to the higher number of MHC and hospital check-ups
in the IA group. Underutilisation of MHC services was
more evident in the non-IA group than in the IA group,
suggesting that perhaps mothers with prior IA are psycho-
logically more aware of their pregnancy and want to ensure
the best possible follow-up for their future offspring.
Fertilisation procedures were reported more often in
the primiparous group, indicating that infertility after an
IA is not a common problem, which supports review by
Lowit et al. [20]. Gestational DM first emerged as being
present more often in the IA group. However, after
Table 5 Interpregnancy intervals by statistically significant study variables
Yes No
n % N % p
Late first visit to MHC
<6 months 10 9.52 95 90.48 <0.0001
6−12 months 30 16.85 148 83.15
>12 months 305 6.65 4,283 93.35
Participation to first trim serum screening
<6 months 13 12.38 92 87.62 <0.0001
6−12 months 41 23.03 137 76.97
>12 months 1605 34.98 2,983 65.02
Placenta sample taken
<6 months 2 1.90 103 98.10 0.0003
6−12 months 7 3.93 171 96.07
>12 months 41 0.89 4,547 99.11
Blood glucose tolerance test performed
<6 months 24 22.86 81 77.14 <0.0001
6−12 months 51 28.65 127 71.35
>12 months 2,144 46.73 2,444 53.27
Diagnoses O14.0
<6 months 5 4.76 100 95.24 0.0073
6−12 months 5 2.81 173 97.19
>12 months 64 1.39 4,524 98.61
Diagnoses 014.0/1/9
<6 months 7 6.67 98 93.33 0.0067
6−12 months 8 4.49 170 95.51
>12 months 111 2.42 4,477 97.58
Diagnoses O36.5
<6 months 2 1.90 103 98.10 0.0153
6−12 months 7 3.93 171 96.07
>12 months 61 1.33 4,527 98.67
Number of check-ups at hospital Number of all follow-up visits
Mean (SD) 95 % CI P Mean (SD) 95 % CI p
<6 months 3.7 (0.3) 3.2−4.3 0.0376 17.9 (0.1) 16.9−18.8 0.0294
6−12 months 3.5 (0.2) 3.1−3.9 16.8 (0.4) 16.1−17.5
>12 months 3.1 (0.0) 3.0−3.2 16.6 (0.1) 16.5−16.8
Diagnoses O14.0: Mild to moderate pre-eclampsia
O14.0/1/9: Mild to moderate pre-eclampsia/Severe pre-eclampsia/Unspecified pre-eclampsia
O36.5: Maternal growth for known or suspected poor fetal growth
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adjusting the analyses for confounding factors, the differ-
ence was no longer evident, possibly due to the higher
rate of overweight and aged mothers in the IA group.
More frequent pathological BG tolerance tests were first
evident in IA group, but after adjusting the analyses, this
difference disappeared. Participating in the BG tolerance
test became statically significant only after the adjust-
ment, indicating that risk factors for gestational DM are
more often seen in non-IA mothers compared to IA
mothers. Any serious complications during a following
pregnancy resulting from a prior IA were not evident in
this study.
Short IPI (<12 months) was more common in young
mothers, mothers living alone and those who continued
to smoke after the first trimester of the on-going preg-
nancy. Even though we were unable to evaluate the edu-
cational level or occupation of the mothers due to poor
documentation, these findings of age, habitation and
smoking are generally considered to be partial indicators
of a low socioeconomic status. Late first visits to MHC
services are most common in mothers with IPI = 6–12
months when compared to mothers with IPI <6 months
or IPI >12 months. This may contribute to the results of
mothers with IPI >6 months participating more often in
the first trimester serum screening test than mothers
with shorter IPIs, possibly because they have missed the
time window for the screening test. More frequent par-
ticipation in the placenta sample testing in mothers with
IPI ≤12 months might be explained by the late first visit
and missing the first trimester serum screening test.
Therefore, if anything pathological is suspected in the
first trimester ultrasound screening test, these mothers
are guided to the placenta sample test/amniotic fluid
sample test. Presence of preeclampsia among IA
mothers did not differ from the non-IA mothers in this
study. However, in IA mothers, preeclampsia was more
common the shorter the IPI was.. This all contributes to
the higher number of hospital and total follow-up visits
in mothers with shorter IPIs compared to mothers with
longer IPIs. Also, maternal care for known or suspected
poor foetal growth was more common IPI = 6–12
months than shorter or longer IPIs. After evaluating the
literature [21–23], we suggest that one reason for this
could be the higher rate of on-going smoking in short-IPI
mothers even after the first trimester of the pregnancy.
According to the 2014 perinatal statistics issued by the
National Institute for Health and Welfare [24], the mean
BMI for all women giving birth was 24.5 kg/m2, with
approximately 35 % of the mothers being overweight. In
addition, 15.3 % of all parturients smoked during
pregnancy, with 46 % of these women stopping smoking
during pregnancy. A study conducted from 1989 to 2001
[25] examined the effect of IA on the background factors
and pregnancy parameters of all pregnant women in the
Kuopio region in Finland. Exclusion criteria included
multiple pregnancies and foetal structural anomalies.
The study concluded that IAs were associated with a
maternal age older than 35 years, unemployment, an
unmarried status, low educational level, smoking, alco-
hol consumption, an overweight condition and chronic
illnesses in general, even though the proportions of
women with DM or high blood pressure did not vary
between the groups. Compared to our study, findings of
overweight and smoking during pregnancy in the
Kuopio study parallel our findings of IA first-time
mothers. These divergent findings may be due to the dif-
ferences in the IA groups in these studies (our first-time
mothers vs. all mothers in the Kuopio study).
The strengths of this study are its reliance on the
registry-based parameters of the participants and the fact
that we were allowed to combine the National Birth
Registry records of all of Finland in the years 2008–2010
with the records from the Induced Abortion Registry in
order to determine the absolute value of different pa-
rameters examined here. No participants were contacted
and no questionnaires were completed, thus excluding
personal feelings (positive or negative) concerning IA or
maternity health care visits. In addition, we felt that all
of the participants were in an equal position regarding
MHC follow-up, as none of the mothers had prior deliv-
eries and had therefore not attended MHC follow-ups
before. In addition, we could assume that, as first-time
mothers, there was no stress of prior offspring contribut-
ing to these pregnancy follow-up parameters. It would
have been interesting to report the symptoms or feelings
the mothers themselves may have experienced during
their pregnancy in addition to these registry-based facts.
We conclude that in pregnancy follow-up parameters,
there are no significant risks evident regarding the upcom-
ing delivery. Prior findings on IAs’ association with pre-
term birth [9–12] were not evident in our study in any of
the scales routinely monitored in MHCs. In addition, dif-
ferences in the most common diagnoses were not seen
when comparing IA and non-IA mothers. However, short
IPI seemed to elevate the risk for certain pregnancy com-
plications (preeclampsia and maternal care for known or
suspected poor foetal growth). Interestingly, a more fre-
quent pathological BG tolerance test was evident in the
first analysis between the groups (Table 2), indicating a
higher incidence of gestational DM that was also seen
among the 10 most common diagnoses during the on-
going pregnancy (Table 3). However, demographic con-
founding characteristics affected both of these variables
because, after adjusting for confounding factors, neither
difference was observed. Our future study will examine
whether the trend of these pregnancy follow-up findings
will continue to be seen in the delivery parameters and
the perinatal period in the same sample of mothers. The
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importance of participating in MHC follow-ups as sched-
uled and thus being able to participate in the first trimes-
ter serum screening test could be emphasised for all of the
mothers during their first visit to the MHC in order to in-
crease participation in this screening test and perhaps de-
crease the number of amniotic fluid samples taken in the
IA group. The IPI was found to affect the next pregnancy
follow-up from the onset by increasing the risk for a late
first visit to an MHC, complicating the follow-up period
and predisposing the mother to additional screening tests
and follow-up visits to the hospital. Preeclampsia and poor
foetal growth were risk outcomes for short IPI; thus, pos-
sible IPI should be inquired about during the first visit to
the MHC in the beginning of the pregnancy.
Conclusion
After examining the data of the first-time mothers covering
all of Finland in the years 2008–2010, we suggest that IA
may be associated with overweight before the next preg-
nancy and smoking after the first trimester of the on-going
pregnancy. IA mothers tend to use MHC services slightly
more than non-IA mothers. No association between in-
duced abortion and preeclampsia, hypertension, gestational
diabetes or preterm premature rupture of membranes was
evident in our study. Short IPI seems to contribute to late
first visits to MHCs, adding extra screening procedures to
the pregnancy follow-up and burdening the otherwise
well-functioning MHC services. Furthermore, our findings
suggest that foetal growth and preeclampsia need to be
monitored carefully with first-time mothers with short
IPIs after IA, although more thorough research in this sub-
ject is needed. Already when performing the IA, it could
be beneficial to inform the women about the importance
of adequate MHC visits in the possible following preg-
nancy. In addition to the adverse effects of the IA, it is re-
assuring to find positive outcomes of the procedure, that
is, that IA is protective against secondary infertility.
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